Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Recap: Catalyst Biosciences Q1 Earnings

 

Catalyst Biosciences (NASDAQ:CBIO) reported its Q1 earnings results on Monday, May 9, 2022 at 08:30 AM.

Here's what investors need to know about the announcement.

Earnings

Catalyst Biosciences missed estimated earnings by 4.55%, reporting an EPS of $-0.46 versus an estimate of $-0.44.

Revenue was down $673.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.06 which was followed by a 0.02% increase in the share price the next day.

Here's a look at Catalyst Biosciences's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.59 -0.66 -0.69 -0.64
EPS Actual -0.65 -0.80 -0.64 -0.79
Revenue Estimate 170.00K 670.00K 330.00K 970.00K
Revenue Actual 2.44M 2.30M 1.13M 1.47M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Catalyst Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.